NCT07470190

Brief Summary

A randomized controlled trial will be conducted to get the expected outcomes. Patients of both gender groups with unilateral shoulder pain will be selected with age range 40-60 years from Sehat medical complex and randomly allocated into four groups (Group A, B, C and D) of two different trials (Trial I and Trial II). The sample size will be 120 patients for both trials. Musculoskeletal ultrasound, goniometry, pain pressure threshold, dynamometer and functional indices will be used to measure the tendon thickness, range of motion, pain, muscle strength and function level. The group A will get BFRT, Group B will get ESWT, group c will get the combination of both and group D will be the Control group (Routine physical therapy). In Trial II the group A will get BFRT, Group B will get Eccentric Training, Group C will get combination of both A \& B and group D will be control group. data will be collected at baseline, 4th week, 8th week and 12 week of interventions. For data analysis SPSS version 25 will be used. Repeated measures ANOVA will be applied to compare the quantitative data within and between the groups. Post-Hoc test Tukey and Bonferroni correction will be used. The level of significance will be set at 5% (P\<0.05).

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
2mo left

Started Feb 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress60%
Feb 2026Aug 2026

Study Start

First participant enrolled

February 23, 2026

Completed
2 days until next milestone

First Submitted

Initial submission to the registry

February 25, 2026

Completed
16 days until next milestone

First Posted

Study publicly available on registry

March 13, 2026

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 23, 2026

Expected
7 days until next milestone

Study Completion

Last participant's last visit for all outcomes

August 30, 2026

Last Updated

March 13, 2026

Status Verified

March 1, 2026

Enrollment Period

6 months

First QC Date

February 25, 2026

Last Update Submit

March 9, 2026

Conditions

Outcome Measures

Primary Outcomes (5)

  • Shoulder Joint Range of Motion from 0-180 degree

    shoulder joint ROM will be measured by Goniometer having 360 degree or inclinometer

    12 weeks

  • MSK Ultrasound for shoulder

    tendon thickness in long (mm) and short axis (mm)

    12 weeks

  • Shoulder Functional scale

    Quick-DASH (Quick-Disability of arm shoulder and hand) functional scale, it is 11 items scale with response range 0-5 on. 0 is no disability and 100 shows severe disability. The scale have 5 response options much worse, somewhat worse, unchanged, somewhat better, much better

    12 weeks

  • Shoulder Joint PAIN

    NPRS 0-10 , 10 is the worse imaginable pain and 0 is no pain

    12 WEEKS

  • Shoulder Muscle Strength

    Manual muscle testing and Dynamometer

    12 weeks

Study Arms (4)

Group A (Blood Flow Restriction Therapy)

EXPERIMENTAL

4 Sets of exercise with restriction cuff 30,15,15,15 with cable system pulley

Other: Blood flow Restriction therapy

Group B (Extracorporeal Shock wave therapy)

EXPERIMENTAL

10 minutes shocks of 2000 J/session

Device: ESWT

Group C (Combination of BFRT+ESWT)

EXPERIMENTAL

Interventional study group Combination therapy

Other: Blood flow Restriction therapyDevice: ESWT

Control Group D

SHAM COMPARATOR

Control group with routine physical therapy

Other: Control

Interventions

BFRT 4 Sets of exercise with restriction cuff 30,15,15,15 with cable system pulley ESWT 10 minutes shocks of 2000 J/session

Also known as: BFRT, ESWT
Group A (Blood Flow Restriction Therapy)Group C (Combination of BFRT+ESWT)
ESWTDEVICE

10 minutes shocks of 2000 J/session

Also known as: Shock wave therapy
Group B (Extracorporeal Shock wave therapy)Group C (Combination of BFRT+ESWT)
ControlOTHER

Electric heating pad (Besmed, Taiwan) 10 minutes, TENS (Comfy Stim, Taiwan Model #: EV-806) 10 minutes

Also known as: Routine physical therapy
Control Group D

Eligibility Criteria

Age40 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • unilateral shoulder pain
  • both gender group
  • two positive tests of (Neer impingement test, Hawkins-Kendy test, Empty can test),
  • shoulder pain history up to 3 months
  • not receiving any physiotherapy last 3 months.
  • not receiving pain medications (NSAIDS) for last 15 days.

You may not qualify if:

  • referred shoulder pain
  • limited shoulder ROM less then 90 degree
  • previous shoulder surgery, intra articular injection or nerve block last 6 months.
  • patient with 180 mmHg blood pressure/uncontrolled BP
  • upper limb fracture, uncontrolled diabetes, open wounds, fistula and vascular surgery.
  • pregnant woman or 6 month history of pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sehat Medical Complex/UOL/UVAS

Lahore, Punjab Province, 54000, Pakistan

RECRUITING

Related Publications (16)

  • Lambert B, Hedt C, Daum J, Taft C, Chaliki K, Epner E, McCulloch P. Blood Flow Restriction Training for the Shoulder: A Case for Proximal Benefit. Am J Sports Med. 2021 Aug;49(10):2716-2728. doi: 10.1177/03635465211017524. Epub 2021 Jun 10.

    PMID: 34110960BACKGROUND
  • Yoshiura K, Stamatakis HC, Welander U, McDavid WD, Shi XQ, Ban S, Kawazu T, Tatsumi M, Kanda S. Physical evaluation of a system for direct digital intra-oral radiography based on a charge-coupled device. Dentomaxillofac Radiol. 1999 Sep;28(5):277-83. doi: 10.1038/sj/dmfr/4600457.

    PMID: 10490745BACKGROUND
  • Kara D, Ozcakar L, Demirci S, Huri G, Duzgun I. Blood Flow Restriction Training in Patients With Rotator Cuff Tendinopathy: A Randomized, Assessor-Blinded, Controlled Trial. Clin J Sport Med. 2024 Jan 1;34(1):10-16. doi: 10.1097/JSM.0000000000001191. Epub 2023 Sep 14.

    PMID: 37706671BACKGROUND
  • Jones JW, McCullough LB. Consent for an intraoperative video record. J Vasc Surg. 2001 Dec;34(6):1133-4. doi: 10.1067/mva.2001.119949. No abstract available.

    PMID: 11743574BACKGROUND
  • Ackmann T, Schneider KN, Schorn D, Rickert C, Gosheger G, Liem D. Comparison of efficacy of supraspinatus tendon tears diagnostic tests: a prospective study on the "full-can," the "empty-can," and the "Whipple" tests. Musculoskelet Surg. 2021 Aug;105(2):149-153. doi: 10.1007/s12306-019-00631-0. Epub 2019 Nov 5.

    PMID: 31691179BACKGROUND
  • Harrer J, Lonsky V, Dominik J, Zacek P, Sistek J, Harrerova L, Knap J. [Coronary revascularization in diffuse atherosclerosis of the anterior descending coronary artery]. Rozhl Chir. 1997 Jul;76(7):342-8. Czech.

    PMID: 9446250BACKGROUND
  • Dube MO, Ingwersen KG, Roy JS, Desmeules F, Lewis J, Juul-Kristensen B, Vobbe J, Jensen SL, McCreesh K. Do therapeutic exercises impact supraspinatus tendon thickness? Secondary analyses of the combined dataset from two randomized controlled trials in patients with rotator cuff-related shoulder pain. J Shoulder Elbow Surg. 2024 Sep;33(9):1918-1927. doi: 10.1016/j.jse.2024.03.055. Epub 2024 May 16.

    PMID: 38762149BACKGROUND
  • Chew E, Lee Day A, Nazarian LN, Kohler M. Basic Musculoskeletal Ultrasound. Med Clin North Am. 2025 Jan;109(1):137-161. doi: 10.1016/j.mcna.2024.06.007. Epub 2024 Aug 3.

    PMID: 39567090BACKGROUND
  • De Misa RF, Azana JM, Bellas C, Perez B, Rocamora A, Ledo A. Mycosis fungoides with signet-ring cells and monoclonal gammopathy. Int J Dermatol. 1994 Sep;33(9):652-3. doi: 10.1111/j.1365-4362.1994.tb02930.x. No abstract available.

    PMID: 8002167BACKGROUND
  • Shulman CE, Marshall T, Dorman EK, Bulmer JN, Cutts F, Peshu N, Marsh K. Malaria in pregnancy: adverse effects on haemoglobin levels and birthweight in primigravidae and multigravidae. Trop Med Int Health. 2001 Oct;6(10):770-8. doi: 10.1046/j.1365-3156.2001.00786.x.

    PMID: 11679125BACKGROUND
  • Mini E, Grassi F, Cherubino P, Nobili S, Periti P. Preliminary results of a survey of the use of antimicrobial agents as prophylaxis in orthopedic surgery. J Chemother. 2001 Nov;13 Spec No 1(1):73-9. doi: 10.1179/joc.2001.13.Supplement-2.73.

    PMID: 11936384BACKGROUND
  • Skimming JW, Banner MJ, Spalding HK, Jaeger MJ, Burchfield DJ, Davenport PW. Nitric oxide inhalation increases alveolar gas exchange by decreasing deadspace volume. Crit Care Med. 2001 Jun;29(6):1195-200. doi: 10.1097/00003246-200106000-00022.

    PMID: 11395602BACKGROUND
  • Matsunaga H, Iida T, Fukushima T, Santa T, Homma H, Imai K. Boron trifluoride-etherate (Lewis acid) as an efficient acid at cyclization/cleavage reaction of D/L-amino acids affording the retention of their original configuration in the Edman sequencing method of peptides. Biomed Chromatogr. 1996 Mar-Apr;10(2):95-6. doi: 10.1002/(SICI)1099-0801(199603)10:23.0.CO;2-H.

    PMID: 8924735BACKGROUND
  • Gagnon F, Dagenais GR, Robitaille NM, Lupien PJ. Impact of systolic and diastolic blood pressure on ischemic vascular diseases in French-Canadian men from 1974 to 1990. Can J Cardiol. 1994 Jan-Feb;10(1):97-105.

    PMID: 8111677BACKGROUND
  • Adler RS

    BACKGROUND
  • Abdul-Karim S,Abdul-Hamid MS,Ho CA,Ling J

    BACKGROUND

MeSH Terms

Interventions

Blood Flow Restriction TherapyExtracorporeal Shockwave Therapy

Intervention Hierarchy (Ancestors)

Exercise TherapyRehabilitationAftercareContinuity of Patient CarePatient CareTherapeuticsPhysical Therapy ModalitiesUltrasonic TherapyDiathermyHyperthermia, Induced

Central Study Contacts

imran Ghafoor, M Phil

CONTACT

Sahar Ijaz, PhD Anatomy

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: 4 arm RCT parallels study design
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 25, 2026

First Posted

March 13, 2026

Study Start

February 23, 2026

Primary Completion (Estimated)

August 23, 2026

Study Completion (Estimated)

August 30, 2026

Last Updated

March 13, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will share

the study protocol

Shared Documents
STUDY PROTOCOL
Time Frame
12 weeks till the trail is recutting
Access Criteria
by email, any researcher
More information

Locations